Skip to content

MELINTA THERAPEUTICS, INC. /NEW/: 10-K filed 2014-02-28

What MELINTA THERAPEUTICS, INC. /NEW/ reported in its annual report filed 2014-02-28 (fiscal FY 2013): 31 published measures, 125 facts as tagged in accession 0001564590-14-000446.

This filing

Form
10-K (annual report)
Filed
2014-02-28
Fiscal period
fiscal FY 2013
Accession
0001564590-14-000446 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All MELINTA THERAPEUTICS, INC. /NEW/ filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-3199,007,818USD
At 2012-12-3170,738,346USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-12-3129,032,428USD
At 2012-12-3112,967,994USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-3169,975,390USD
At 2012-12-3157,770,352USD
At 2011-12-31-96,685,150USD
At 2010-12-31-72,215,027USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-12-3196,502,918USD
At 2012-12-3170,108,754USD
At 2011-12-3115,602,264USD
At 2010-12-3120,047,997USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-45,034,706USD365
2012-10-01 to 2012-12-31-6,568,000USD92
2012-01-01 to 2012-12-31-24,226,789USD366
2012-07-01 to 2012-09-30-4,981,000USD92
2012-04-01 to 2012-06-30-9,528,000USD91
2012-01-01 to 2012-03-31-3,150,000USD91
2011-01-01 to 2011-12-31-21,220,779USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-32,440,868USD365
2012-01-01 to 2012-12-31-23,106,627USD366
2011-01-01 to 2011-12-31-18,314,636USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-12-31134,125USD365
2012-01-01 to 2012-12-318,437USD366
2011-01-01 to 2011-12-3113,389USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-10-01 to 2013-12-312,073,000USD92
2013-01-01 to 2013-12-317,812,966USD365
2013-07-01 to 2013-09-301,172,000USD92
2013-04-01 to 2013-06-304,567,000USD91

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-12-3158,969,157USD365
2012-01-01 to 2012-12-3177,621,554USD366
2011-01-01 to 2011-12-3113,882,292USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-134,125USD365
2012-01-01 to 2012-12-31-8,437USD366
2011-01-01 to 2011-12-31-13,389USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-12-31-166,260,233USD
At 2012-12-31-121,225,527USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-12-31137,721USD
At 2012-12-3143,217USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-12-313,211,802USD365
2012-01-01 to 2012-12-311,669,262USD366
2011-01-01 to 2011-12-31443,785USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-16,148,000USD92
2013-01-01 to 2013-12-31-42,920,176USD365
2013-07-01 to 2013-09-30-12,914,000USD92
2013-04-01 to 2013-06-30-3,841,000USD91
2013-01-01 to 2013-03-31-10,018,000USD90
2012-10-01 to 2012-12-31-6,238,000USD92
2012-01-01 to 2012-12-31-22,937,535USD366
2012-07-01 to 2012-09-30-4,651,000USD92
2012-04-01 to 2012-06-30-9,201,000USD91
2012-01-01 to 2012-03-31-2,848,000USD91
2011-01-01 to 2011-12-31-20,579,388USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-3198,537,066USD
At 2012-12-3170,373,735USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-10-01 to 2013-12-31684,000USD92
2013-01-01 to 2013-12-312,132,223USD365
2013-07-01 to 2013-09-30736,000USD92
2013-04-01 to 2013-06-30384,000USD91
2013-01-01 to 2013-03-31328,000USD90
2012-10-01 to 2012-12-31331,000USD92
2012-01-01 to 2012-12-311,396,818USD366
2012-07-01 to 2012-09-30331,000USD92
2012-04-01 to 2012-06-30328,000USD91
2012-01-01 to 2012-03-31407,000USD91
2011-01-01 to 2011-12-31722,454USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-12-3110,861,590USD
At 2012-12-315,344,709USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-12-316,273,602USD
At 2012-12-312,171,633USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-01-01 to 2013-12-3150,733,142USD365
2012-01-01 to 2012-12-3122,937,535USD366
2011-01-01 to 2011-12-3120,579,388USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-10-01 to 2013-12-3115,683,000USD92
2013-01-01 to 2013-12-3141,299,695USD365
2013-07-01 to 2013-09-3011,919,000USD92
2013-04-01 to 2013-06-306,327,000USD91
2013-01-01 to 2013-03-317,371,000USD90
2012-10-01 to 2012-12-314,413,000USD92
2012-01-01 to 2012-12-3116,869,078USD366
2012-07-01 to 2012-09-303,156,000USD92
2012-04-01 to 2012-06-307,424,000USD91
2012-01-01 to 2012-03-311,876,000USD91
2011-01-01 to 2011-12-3116,871,825USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-12-3133,200,341shares
At 2012-12-3124,903,774shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-12-31236,202,423USD
At 2012-12-31178,970,975USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2013-12-3115,895,245USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-12-31336,072USD
At 2012-12-31282,084USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-12-31198,351USD
At 2012-12-31238,867USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-12-31391,657USD
At 2012-12-31341,918USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-16,830,000USD92
2013-01-01 to 2013-12-31-45,034,706USD365
2013-07-01 to 2013-09-30-13,647,000USD92
2013-04-01 to 2013-06-30-4,213,000USD91
2013-01-01 to 2013-03-31-10,345,000USD90
2012-10-01 to 2012-12-31-6,568,000USD92
2012-01-01 to 2012-12-31-24,540,377USD366
2012-07-01 to 2012-09-30-4,981,000USD92
2012-04-01 to 2012-06-30-9,528,000USD91
2012-01-01 to 2012-03-31-3,464,000USD91
2011-01-01 to 2011-12-31-24,983,840USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-10-01 to 2013-12-312,538,000USD92
2013-01-01 to 2013-12-319,433,447USD365
2013-07-01 to 2013-09-302,167,000USD92
2013-04-01 to 2013-06-302,081,000USD91
2013-01-01 to 2013-03-312,647,000USD90
2012-10-01 to 2012-12-311,825,000USD92
2012-01-01 to 2012-12-316,068,457USD366
2012-07-01 to 2012-09-301,495,000USD92
2012-04-01 to 2012-06-301,777,000USD91
2012-01-01 to 2012-03-31972,000USD91
2011-01-01 to 2011-12-313,707,563USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-01-01 to 2013-12-3139,622USD365
2012-01-01 to 2012-12-3147,140USD366
2011-01-01 to 2011-12-3175,141USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-2,114,530USD365
2012-01-01 to 2012-12-31-1,289,254USD366
2011-01-01 to 2011-12-31-641,391USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2013-01-01 to 2013-12-311,208,526USD365
2012-01-01 to 2012-12-31920,514USD366

Inspect the source

Entity
MELINTA THERAPEUTICS, INC. /NEW/ / CIK 0001461993
Captured
SEC response SHA-256
a91f8f211753f3d9ac6e05de33d49dcc2bb8e612652c27bc45fa4809eebdc607

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001461993.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))